- Home
- BDSX vs ISSC Comparison
BDSX vs ISSC Comparison
Compare BDSX & ISSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- ISSC
- Stock Information
- Founded
- BDSX 2005
- ISSC 1988
- Country
- BDSX United States
- ISSC United States
- Employees
- BDSX N/A
- ISSC N/A
- Industry
- BDSX Precision Instruments
- ISSC EDP Services
- Sector
- BDSX Health Care
- ISSC Technology
- Exchange
- BDSX Nasdaq
- ISSC Nasdaq
- Market Cap
- BDSX 115.4M
- ISSC N/A
- IPO Year
- BDSX 2020
- ISSC 2000
- Fundamental
- Price
- BDSX $0.63
- ISSC $6.61
- Analyst Decision
- BDSX Strong Buy
- ISSC
- Analyst Count
- BDSX 3
- ISSC 0
- Target Price
- BDSX $2.93
- ISSC N/A
- AVG Volume (30 Days)
- BDSX 270.4K
- ISSC 85.9K
- Earning Date
- BDSX 05-07-2025
- ISSC 05-12-2025
- Dividend Yield
- BDSX N/A
- ISSC N/A
- EPS Growth
- BDSX N/A
- ISSC 3.71
- EPS
- BDSX N/A
- ISSC 0.38
- Revenue
- BDSX $71,323,000.00
- ISSC $53,858,686.00
- Revenue This Year
- BDSX $32.90
- ISSC $31.35
- Revenue Next Year
- BDSX $24.65
- ISSC $16.39
- P/E Ratio
- BDSX N/A
- ISSC $17.41
- Revenue Growth
- BDSX 45.30
- ISSC 43.24
- 52 Week Low
- BDSX $0.59
- ISSC $4.91
- 52 Week High
- BDSX $2.04
- ISSC $12.17
- Technical
- Relative Strength Index (RSI)
- BDSX 31.91
- ISSC 40.23
- Support Level
- BDSX $0.59
- ISSC $6.13
- Resistance Level
- BDSX $0.75
- ISSC $6.81
- Average True Range (ATR)
- BDSX 0.08
- ISSC 0.27
- MACD
- BDSX -0.01
- ISSC 0.07
- Stochastic Oscillator
- BDSX 12.53
- ISSC 47.06
Stock Price Comparison Chart: BDSX vs ISSC
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.